Anti-Il-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection Than Anti-TNF- Antibody in Mice

Clinical and Developmental Immunology
doi 10.1155/2011/404929
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Anti-Interleukin 6 Receptor Antibody Treatment in Rheumatic Disease

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Anti-Interleukin-6 Receptor Antibody Reduces Neuropathic Pain Following Spinal Cord Injury in Mice

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Orphan Designation: Humanised Anti-Il-6 Receptor Monoclonal Antibody, Treatment of Neuromyelitis Optica Spectrum Disorders

Case Medical Research
2019English

Anti-Interleukin-6 Receptor Antibody Therapy —From Bedside to Bench—

Japanese Journal of Clinical Immunology
2006English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Cut Off Selection in Anti-Acetylcholine Receptor Antibody Determination.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1994English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

Deficiencies in Anti-Acetylcholine Receptor Antibody Measurement in Myasthenia Gravis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy